Introduction {#Sec1}
============

The COVID-19 is a novel heat-sensitive coronavirus. Based on evolutionary research, it has been found that the virus has originated from animals like bats, rodents, and birds \[[@CR1]\]. In early December 2019, the first cases of pneumonia of unknown etiology were observed in Wuhan, the capital of Hubei Province in China \[[@CR2]\]. The pathogen, which was a single-stranded enveloped coronavirus RNA \[[@CR3]\], was called acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and the course of the disease caused by the virus is pathologically somewhat similar to that of severe acute respiratory syndrome (SARS) \[[@CR4]\]. So far, seven types of coronaviruses have been identified that can infect humans \[[@CR4]--[@CR6]\]. Viruses that cause severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), and the coronavirus disease (COVID-19) have zoonotic origins \[[@CR6]\] and are transmitted from person to person \[[@CR7]\]. About 13.9% of patients with COVID-19 died, and about half of those who visited hospitals were discharged after receiving the necessary treatment \[[@CR8]\]. According to the study by Guan et al., 1099 patients in 552 hospitals with COVID-19 and an average age of 47 years were examined. Common manifestations of the virus include fever above 37.5 °C (56.2%), cough (67.8%), and lymphocytopenia (83.2%) \[[@CR9]\]. According to several studies that examined the imaging findings of COVID-19 patients, 69 to 89% of the patients had positive chest CT findings \[[@CR10], [@CR11]\]. Ground-glass opacity (GGO) is frequently observed which has been reported in most studies \[[@CR12], [@CR13]\]. Radiological evaluation often plays a key role in confirming the diagnosis of COVID-19 in suspected cases when test kits are not available. Given the recency of the virus and the lack of sufficient information on patients involved in COVID-19 in Iran, during this study, the imaging findings of patients with COVID-19 were examined in Mazandaran province, located in the north of Iran.

Materials and methods {#Sec2}
=====================

This cross-sectional study was conducted in March 2020 on symptomatic patients who visited the imaging centers of Sari during the coronavirus epidemic. The study population were patients with high clinical suspicion who performed a CT scan because of limited laboratory testing in Iran to confirm the diagnosis and treatment. The CT scanner was a Somatom Emotion 16 by Siemens with a 16-slice configuration. The high-resolution computed tomography (HRCT) in axial sections was used without the contrast material with section thickness of 2 mm. The low-dose protocol (low-dose computed tomography) with radiation conditions of Kvp = 100--120, mAs = 50--100, and pitch = 1 mm was used. The patient was supine in the CT scanner with his/her arm above their head. CT scanning started from the apex to the lowest part of the lungs in a deep inspiration.

The required information, including demographic data such as age, gender, and HRCT results, was collected and recorded in a researcher-made checklist by four radiologists using the PACS system.

Data were analyzed in SPSS 20 using *t* test, chi-square, and Fisher's exact tests, and a *p* \< 0.05 was considered as significant. Finally, due to the very different sample size in the literature, meta-analysis was undertaken using random effect method and Stata software to better compare the reported percentages.

Results {#Sec3}
=======

The study was conducted on 552 symptomatic patients with clinical suspicion who visited for HRCT. The mean age of participants was 51.2 ± 14.8 years, in the range of 16 to 99 years, and the age group of 50 to 59 years with the relative frequency of 25.4% showed the highest involvement (Fig. [1](#Fig1){ref-type="fig"}). In this study, 317 males (57.4%) and 235 females (42.6%) participated with a male/female sex ratio of 1.38.Fig. 1Age distribution of patients with coronavirus 2019

The most common presented findings in patients were ground glass opacity (482 cases, 87.3%), peripheral distribution (455 cases, 82.4%), posterior distribution (450 cases, 81.5%), and anterior distribution (325 cases, 58.9%) (Table [1](#Tab1){ref-type="table"} and Fig. [2](#Fig2){ref-type="fig"}). Figure [2](#Fig2){ref-type="fig"} shows the CT scan finding of 5 patients as examples. There was no significant difference between patients of both genders in the distribution of presented findings. Peripheral distribution (86% vs 79%, *p* = 0.034) along with the findings of round opacity (19.5% vs 12.5%, *p* = 0.02) and single lobe (23.2% vs 13.2%, *p* = 0.003) was significantly higher in patients under 50 compared to those over 50 (Table [1](#Tab1){ref-type="table"}).Table 1Presented findings in HR CT scan of symptomatic patients infected with coronavirus 2019FindingsTotal\
*n* = 552\
Frequency (%)Female\
*n* = 235\
Frequency (%)Male\
*n* = 317\
Frequency (%)*p* valueAge ≤ 50\
*n* = 271\
Frequency (%)Age \> 50\
*n* = 281\
Frequency (%)*p* valueGround glass482 (87.3)205 (87.2)277 (87.4)1239 (88.2)243 (86.5)0.609Acinar shadows261 (47.3)118 (50.2)143 (45.1)0.262127 (46.9)134 (47.7)0.865Bailateral/multilobar involvement  Minimal127 (23)65 (27.7)62 (19.6)0.18676 (28)51 (18.1)0.053  Mild152 (27.5)56 (23.8)96 (30.3)75 (27.7)77 (27.4)  Moderate184 (33.3)78 (33.2)106 (33.4)83 (30.6)101 (35.9)  Severe44 (8)17 (7.2)27 (8.5)17 (6.3)27 (9.6)Single lobe100 (18.1)45 (19.1)55 (17.4)0.65563 (23.2)37 (13.2)0.003Peripheral distribution455 (82.4)192 (81.7)263 (83)0.735233 (86)222 (79)0.034Central distribution280 (50.7)111 (47.2)169 (53.3)0.169131 (48.3)149 (53)0.307Posterior distribution450 (81.5)194 (82.6)256 (80.8)0.658222 (81.9)228 (81.1)0.827Anterior distribution325 (58.9)136 (59.6)189 (58.9)0.727153 (56.5)172 (61.2)0.262Round opacities89 (16.1)43 (18.3)46 (14.5)0.24354 (19.9)35 (12.5)0.02linear opacities41 (7.4)17 (7.2)24 (7.6)114 (5.2)27 (9.6)0.052Crazy paving8 (1.4)2 (0.9)6 (1.9)0.4772 (0.7)6 (2.1)0.286Reversed halo9 (1.6)4 (1.7)5 (1.6)16 (2.2)3 (1.1)0.332Fig. 2**a** Bilateral and anterior to posterior peripheral ground glass opacities (white arrows). **b** Ground glass opacity in upper lobe (black arrow) and consolidation in lower lobe of right lung (red arrow). **c** Bilateral and peripheral ground glass opacities (white arrows). **d** Consolidation in right lower lobe (black arrow). **e** Right-sided pleural effusion (red arrow). **f** Bilateral and anterior to posterior peripheral ground glass opacities (white arrows) with peribronchovascular distribution in right middle lobe (black arrow). **g** Bilateral and anterior to posterior peripheral ground glass opacities (black arrows). **h** Small lymphadenopathies in middle mediastinum (white arrow)

The most common inconsistent findings in the study population were pleural effusion (42 cases, 7.6%), peribronchovascular distribution (42 cases, 7.6%), and lymphadenopathy (28 cases, 5.1%) (Table [2](#Tab2){ref-type="table"} and Fig. [2](#Fig2){ref-type="fig"}). There was no significant difference between patients of both genders in the distribution of inconsistent findings. The age distribution of inconsistent findings indicated that pleural effusion was significantly higher (*p* = 0.037) in patients over 50 years of age (28 cases, 10%) compared to those under 50 (14 cases, 5.2%) (Table [2](#Tab2){ref-type="table"}).Table 2Inconsistent findings in HR CT scan of symptomatic patients infected with coronavirus 2019FindingsTotal\
*n* = 552\
Frequency (%)Female\
*n* = 235\
Frequency (%)Male\
*n* = 317\
Frequency (%)*p* valueAge ≤ 50\
*n* = 271\
Frequency (%)Age \> 50\
*n* = 281\
Frequency (%)*p* valueTree-in-bud capacities7 (1.3)2 (0.9)5 (1.6)0.7042 (0.7)5 (1.8)0.451Centrilobular distribution5 (0.9)2 (0.9)3 (0.9)11 (0.4)4 (1.4)0.373Peribronchovascular distribution42 (7.6)22 (9.4)20 (6.3)0.19619 (7)23 (8.2)0.633Predominantly nodular opacities12 (2.2)7 (3)5 (1.6)0.3775 (1.8)7 (2.5)0.772Cavitation6 (1.1)2 (0.9)4 (1.3)11 (0.4)5 (1.8)0.217Lymphadenopathy28 (5.1)15 (6.4)13 (4.1)0.24411 (4.1)17 (6)0.335Pleural effusion42 (7.6)21 (8.9)21 (6.6)0.33314 (5.2)28 (10)0.037

Discussion {#Sec4}
==========

CT images with yielded 98% sensitivity play an important role in the diagnosis and evaluation of COVID-19 and can be used as a standard method for rapid diagnosis of COVID-19 to manage patients \[[@CR4]--[@CR16]\]. The present study was conducted on 552 patients with clinical suspicion who referred for HRCT and had signs of involvement in the CT images. The most common presented findings in patients were ground glass opacity, peripheral distribution, and posterior distribution. The prevalence of ground glass opacity in the study population was 87.3%, which varied from 41 to 100% in other studies \[[@CR9], [@CR14], [@CR17]--[@CR28]\], and the prevalence of this finding was 67% given the difference in sample size in different studies and conducting the meta-analysis on these studies (Table [3](#Tab3){ref-type="table"}). Peripheral distribution was the second most common finding in 82.4% of the study population. The prevalence of this finding in other studies ranged from 33 to 98% \[[@CR15]--[@CR21], [@CR23], [@CR25], [@CR27], [@CR28]\]. The meta-analysis conducted on the present study and other studies presented the peripheral distribution with 79% prevalence as the most common CT finding in these patients (Table [3](#Tab3){ref-type="table"}).Table 3CT scan findings in different study and pooled estimation of these findingsAuthorSample sizeGround-glass opacityPeripheral distributionPleural effusionLymphadenopathyHalo signCrazy-pavingGuan, WJ \[[@CR9]\]97556.4Wu, J \[[@CR14]\]8091.0Li, Y \[[@CR15]\]5190.22.00.021.5Bai, HX \[[@CR17]\]42491.080.04.12.7Chung, M \[[@CR18]\]2187.033.019.0Guan, CS \[[@CR19]\]47100.093.689.4Han, R \[[@CR20]\]10860.090.064.040.0Liu, H \[[@CR21]\]5972.098.0Liu, KC \[[@CR22]\]7359.03.4Shi, H \[[@CR23]\]8165.054.0Xu, X \[[@CR24]\]9072.012.0Zhao, W \[[@CR25]\]10186.187.1Zhu, W \[[@CR26]\]3247.0Li, K \[[@CR27]\]5680.487.58.90.0Song, F \[[@CR28]\]517786Zhou, S \[[@CR29]\]6277.49.7Yoon, SH \[[@CR30]\]911.1Majidi, H (Present)55287.382.47.65.11.61.4Pooled estimation (CI95%) with meta-analysis67 (58--76)79 (66--92)7 (−24--39)4 (−26--35)41 (11--72)32 (4--59)

The most common inconsistent findings in patients were pleural effusion, peribronchovascular distribution, and lymphadenopathy. Pleural effusion was 7.6% in the present study, which ranged between 2 and 9.7% in other studies, and the combination of the results of the present study and other studies estimated a 7% pleural effusion (Table [3](#Tab3){ref-type="table"}). Lymphadenopathy in the CT scan was 5.1% higher than the value reported by other studies, such that this finding was not observed in two studies \[[@CR15], [@CR27]\] while it was 2.7% in one study \[[@CR17]\] and 6% in another study. The total estimation was 4% (Table [3](#Tab3){ref-type="table"}).

A halo sign of 1.6% was an uncommon finding in the present study, while other studies reported 11.1 to 64% \[[@CR15], [@CR20], [@CR29]\]. The cumulative rate of the present study and other studies estimated a 41% rate of halo sign (Table [3](#Tab3){ref-type="table"}). In addition, a similar situation occurred with crazy-paving as an uncommon finding in the present study which varied from 1.4% in this study to 12--89% in other studies \[[@CR18]--[@CR20], [@CR24]\]. The meta-analysis of the present study and other studies provided a rate of 32% for this finding.

Most CT findings in the present study showed no significant difference between genders and age groups, except for peripheral distribution, round opacities, single lobe, and pleural effusion, which showed a significant difference between the age groups under and over 50 years old. In a study by Song et al., ground glass opacity and consolidative opacities were significantly different between age groups under and over 50 years old \[[@CR28]\].

Mean age of participants was 51.2 ± 14.8 years. The male/female sex ratio was 1.38. Similar to the results of the present study, in a study conducted on 1099 patients in China, the mean age of patients was 47 years, and the same sex ratio was observed \[[@CR9]\].

The present study utilized an acceptable sample size which is one of the strengths of the present study. One of the weaknesses of the study is the lack of diagnostic confirmation by RT-PCR test, which was not possible for all patients due to the epidemic that occurred and the limited number of tests in Iran at the beginning of the epidemic. Other limitations of the study include the lack of a standard reporting format for the chest CT scans in these patients.

Conclusion {#Sec5}
==========

Compared to other studies, the findings of the present study reported the peripheral distribution and ground glass opacity as important findings in the study population and by summarizing the results of studies, it can be concluded that peripheral distribution is the most common finding in these patients.
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